Page 59 - ADULT-ONSET ASTHMA PREDICTORS OF CLINICAL COURSE AND SEVERITY

BIOMARKERS TO IDENTIFY SPUTUM EOSINOPHILIA IN DIFFERENT ADULT ASTHMA PHENOTYPES
19. Westerhof GA, Vollema EM, Weersink EJ, Reinartz SM, de Nijs SB, Bel EH. Predictors for the development of progressive severity in new-onset adult asthma. J Allergy Clin Immunol 2014; 134:1051-1056.e2.
20. Global Strategy for Asthma Management and Preven on 2014 (update). 2014.] Available from h p:// www.ginasthma.org/local/uploads/ les/GINA_Pocket_2014_Jun11.pdf.
21. Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and de ni on of severe refractory asthma: an interna onal consensus statement from the Innova ve Medicine Ini a ve (IMI). Thorax 2011; 66:910-7.
22. Juniper EF, Bousquet J, Abetz L, Bateman ED. Iden fying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Ques onnaire. Respir.Med. 2006; 100:616-21.
23. Juniper EF, O’Byrne PM, Guya GH, Ferrie PJ, King DR. Development and valida on of a ques onnaire to measure asthma control. European Respiratory Journal 1999; 14:902-7.
24. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, et al. Sputum induc on. Eur.Respir.J Suppl 2002; 37:3s-8s.
25. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An O cial ATS Clinical Prac ce Guideline: Interpreta on of Exhaled Nitric Oxide Levels (FENO) for Clinical Applica ons. American Journal of Respiratory and Cri cal Care Medicine 2011; 184:602-15.
26. Korevaar DA, Westerhof GA, Wang J, Cohen JF, Spijker R, Sterk PJ, et al. Diagnos c accuracy of minimally invasive markers for detec on of airway eosinophilia in asthma: a systema c review and meta-analysis. Lancet Respir Med 2015.
27. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. American Journal of Respiratory and Cri cal Care Medicine 2012; 185:612-9.
28. van Veen IH, ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway in amma on in obese and nonobese pa ents with di cult-to-treat asthma. Allergy 2008; 63:570-4.
29. Cowan DC, Taylor DR, Peterson LE, Cowan JO, Palmay R, Williamson A, et al. Biomarker-based asthma phenotypes of cor costeroid response. J Allergy Clin Immunol 2014.
30. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacer- ba ons of refractory eosinophilic asthma.[Erratum appears in N Engl J Med. 2011 Feb 10;364(6):588]. New England Journal of Medicine 2009; 360:973-84.
31. Liang Z, Zhao H, Lv Y, Li R, Dong H, Liu L, et al. Moderate accuracy of peripheral eosinophil count for predic ng eosinophilic phenotype in steroid-naive non-atopic adult asthma cs. Internal Medicine 2012; 51.
32. Tseliou E, Bessa V, Hillas G, Delimpoura V, Papadaki G, Roussos C, et al. Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma. Chest 2010; 138:107-13.
33. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 2013; 41:716-26.
34. Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, Piacen ni G, et al. Current evidence and future research needs for FeNO measurement in respiratory diseases. Respir Med 2014; 108:830-41.
35. Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG. Blood eosinophil count is a useful biomarker to iden fy pa ents with severe eosinophilic asthma. Ann Am Thorac Soc 2014; 11:531-6.
57